Authors
Loading...
In vitro treatment with HDAC1/2 degrader ARP-47 increased HbF in CD34+ cells, suggesting a new approach for β-hemoglobinopathies.
Borges et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: